We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Vasoproliferative retinal tumors: Clinical presentation and treatment outcome.
- Authors
Kiri, Hardik; Raval, Vishal; Ali, Hasnat; Das, Anthony Vipin; Kaliki, Swathi
- Abstract
Objective: To study the clinical presentation and treatment outcomes of patients with vasoproliferative retinal tumor (VPRT) in India. Methods: Retrospective study of 50 eyes in 47 patients. Results: Of the 50 eyes, 25 (50%) were primary and 25 (50%) were secondary. Common ocular pathologies related to secondary VPRT included retinal detachment (n = 8, 32%) and Coats disease (n = 7, 28%). Overall, the mean age at presentation was 35 years (range; 3–74 years) and included 30 (64%) males and 17 (36%) females. The lesions were unilateral in 44 (94%) patients. Secondary retinal features included intra/subretinal exudation (n = 41, 82%), vascularity (n = 32, 64%), subretinal fluid (n = 21, 42%), retinal neovascularisation (n = 9, 18%) and vitreous hemorrhage (n = 8, 16%). Thirty-four eyes (68%) underwent cryotherapy, of which 16 eyes (47%) received adjunct intravitreal anti-VEGF (12 eyes) or corticosteroid injection (4 eyes). Primary surgery included vitrectomy with/without encirclage and cryotherapy (n = 12, 24%) and plaque brachytherapy (n = 3, 6%). At last follow-up (mean 9.7 months, range 3–67 months), 42 eyes (84%) had complete tumor regression with no improvement in visual outcomes when comparing presenting and final best corrected visual acuity. Comparing primary versus secondary VPRT, secondary VPRT presented a decade earlier (31 vs 40 years), needed surgical intervention (48% vs 20%), had poor tumor control (72% vs 92%) and worse visual outcomes (p < 0.05). Conclusion: VPRTs commonly present as a unilateral lesions in the adult population with equal prevalence of primary and secondary variants. Compared with primary VPRT, secondary VPRTs require surgical treatment and are associated with poor visual outcome.
- Publication
European Journal of Ophthalmology, 2023, Vol 33, Issue 4, p1596
- ISSN
1120-6721
- Publication type
Article
- DOI
10.1177/11206721221149075